ubiquitin
proteasom
system
play
import
role
viru
infect
previou
studi
show
proteasom
inhibitor
could
potenti
affect
hepat
e
viru
hev
replic
studi
found
could
inhibit
hev
hepat
c
viru
hcv
replicationrel
luciferas
activ
subgenom
model
furthermor
treatment
hev
infecti
model
result
dramat
reduct
intracellular
level
hev
rna
surprisingli
concurr
inhibit
express
luciferas
gene
use
control
well
wide
rang
host
gene
consist
total
cellular
rna
protein
content
concurr
reduc
treatment
suggest
nonspecif
antivir
effect
ubiquitin
proteasom
system
up
serv
major
pathway
protein
degrad
modif
eukaryot
cell
util
mani
type
virus
previou
studi
demonstr
up
regul
viral
rnadepend
rna
polymeras
rdrp
mediat
viral
rna
synthesi
addit
up
also
regul
ubiquityl
degrad
viral
structur
protein
thu
repres
potenti
antivir
target
hepat
e
viru
hev
singlestrand
positivesens
rna
viru
belong
famili
hepevirida
small
nonenvelop
viru
rna
genom
cap
termini
polyadenyl
termini
outbreak
hepat
e
occur
period
throughout
develop
world
typic
caus
acut
selflimit
infect
fulmin
hepat
high
mortal
reach
describ
case
pregnant
women
western
world
hev
mainli
affect
immunocompromis
patient
high
risk
develop
chronic
hepat
howev
proven
medic
avail
treat
hepat
e
recent
studi
report
potent
antivir
effect
wellknown
proteasom
inhibitor
hev
renillaluciferasecoupl
hev
replic
model
author
show
treatment
result
dramat
reduct
hevrel
luciferas
activ
import
find
inspir
us
evalu
effect
two
hev
cell
cultur
model
studi
two
human
hepatoma
cell
line
base
hev
cell
cultur
model
employ
subgenom
hev
replicon
contain
gaussia
luciferas
report
accumul
secret
luciferas
serv
report
hev
replic
fulllength
infecti
model
cell
electropor
fulllength
hev
genom
rna
clone
genbank
access
number
two
firefli
luciferas
cell
model
also
use
cell
line
normal
stabl
express
luciferas
driven
phosphoglycer
kinas
pkg
promot
hepat
c
viru
hcv
also
singlestrand
positivesens
rna
viru
subgenom
cell
cultur
model
gaussia
luciferas
firefli
luciferas
activ
measur
describ
previous
use
lumi
star
optima
luminesc
counter
bmg
lab
tech
offenburg
germani
mtt
assay
perform
describ
previous
absorb
well
read
use
micropl
absorb
reader
biorad
wavelength
nm
rna
isol
use
machereynagel
nucleospin
rna
ii
kit
biok
leiden
netherland
quantifi
use
nanodrop
thermo
de
usa
cdna
prepar
total
rna
use
cdna
synthesi
kit
takara
bio
inc
hev
gapdh
human
retin
pigmentosa
cya
cyclophilin
cyb
cyclophilin
b
cluster
differenti
monophosph
dehydrogenas
quantifi
sybrgreenbas
realtim
pcr
hev
primer
sequenc
sens
antisens
primer
sequenc
housekeep
gene
gapdh
sens
antisens
primer
housekeep
gene
sens
antisens
primer
sequenc
cya
ggcaaatgctggaccc
antisens
tgctggtcttgccattc
sens
primer
cyb
antisens
sens
primer
antisens
sens
primer
antisens
sens
western
blot
cell
seed
plate
treat
h
cell
lysat
heat
minut
follow
load
sampl
onto
sodium
dodecyl
sulfat
polyacrylamid
gel
separ
electrophoresi
mous
bactin
antibodi
use
primari
antibodi
sdspage
electrophoresi
min
v
gel
stain
coomassi
brilliant
blue
solut
distain
consist
previou
studi
treatment
lm
lm
significantli
impair
cellular
metabol
activ
viabil
determin
mtt
assay
h
fig
h
fig
although
minor
inhibitori
effect
observ
cell
treat
fig
nonspecif
effect
proteasom
inhibitor
luciferas
activ
treatment
h
h
b
result
dramat
reduct
luciferas
activ
subgenom
hev
replicon
mean
sd
n
hcv
replicon
mean
sd
n
cell
constantli
express
control
luciferas
gene
control
pgk
promot
mean
sd
n
treatment
strongli
affect
cellular
metabol
activ
viabil
determin
mtt
assay
od
valu
mean
sd
n
although
minor
inhibitori
effect
observ
treatment
lm
h
lm
h
expect
treatment
lm
potent
inhibit
hevreplicationrel
gaussia
luciferas
activ
model
fig
h
h
furthermor
test
proteasom
inhibitor
hepat
c
viru
subgenom
model
consist
inhibit
hcvcoupl
firefli
luciferas
activ
fig
surprisingli
cell
treat
control
firefli
luciferas
activ
driven
pgk
promot
also
potent
inhibit
fig
result
rais
concern
regard
specif
effect
viral
replic
investig
hev
infecti
model
treat
h
rel
level
hev
viral
rna
two
host
refer
gene
gapdh
quantifi
sybrbas
qrtpcr
shown
fig
treatment
lm
result
signific
decreas
intracellular
hev
rna
mean
sd
n
p
respect
strikingli
express
level
two
refer
gene
gapdh
concurr
decreas
addit
express
four
host
gene
test
cya
cyb
also
decreas
simultan
fig
result
confirm
effect
nonspecif
next
measur
rna
concentr
total
protein
content
cell
treatment
found
treatment
lm
lm
drastic
reduc
total
cellular
rna
content
fig
furthermor
cell
treat
lyse
show
reduc
cellular
protein
express
shown
fig
protein
level
intern
refer
bactin
decreas
treatment
lm
lm
total
protein
content
also
reduc
fig
howev
effect
protein
level
less
profound
rna
level
result
suggest
inhibit
express
translat
broad
rang
gene
rather
specif
effect
viral
infect
substanti
evid
suggest
cellular
up
associ
viral
infect
rdrp
essenti
enzym
viral
replic
regul
up
turnip
yellow
mosaic
viru
tymv
sindbi
viru
hepat
viru
hav
hcv
infect
virusencod
proteas
cleav
viral
polyprotein
proteolyt
also
mediat
process
mani
host
protein
matur
proteas
hav
encephalomyocard
viru
emcv
shown
subject
rapid
ubiquitinmedi
protein
degrad
combat
strategi
viral
proteas
shown
contain
deubiquitin
enzym
activ
papainlik
cystein
proteas
sar
coronaviru
hev
footandmouth
diseas
viru
fmdv
abil
hydrolyz
ubiquitin
substrat
therefor
modul
up
repres
potenti
antivir
strategi
treatment
proteasom
inhibitor
shown
decreas
titer
porcin
circoviru
type
earli
stage
infect
treatment
also
shown
decreas
activ
renilla
luciferas
express
hev
replicon
howev
studi
rais
concern
regard
specif
effect
hev
replic
although
confirm
inhibitori
effect
luciferas
activ
hev
hcv
replicon
model
also
inhibit
constitut
express
luciferas
control
cell
furthermor
fulllength
hev
model
although
treatment
reduc
hev
rna
level
also
simultan
inhibit
express
refer
gene
host
gene
demonstr
dramat
decreas
level
total
intracellular
rna
protein
explain
nonspecif
effect
viral
infect
surpris
inhibit
system
could
exert
varieti
effect
cell
physiolog
sinc
up
play
essenti
role
process
cellular
protein
proteasom
promptli
degrad
ubiquityl
protein
protein
import
mediat
cellcycl
progress
apoptosi
shown
induc
express
death
receptor
receptor
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
result
enhanc
sensit
trailinduc
apoptosi
cancer
cell
thu
inhibit
major
intracellular
protein
degrad
pathway
could
nonspecif
affect
viral
infect
fulli
exclud
up
may
also
specif
modul
certain
virus
summari
studi
demonstr
inhibit
hev
infect
proteasom
inhibitor
nonspecif
thu
care
interpret
data
regard
effect
mechan
proteasom
inhibitor
viral
infect
although
proteasom
inhibitor
preclin
phase
test
anticanc
agent
would
call
caution
develop
proteasometarget
antivir
therapi
volum
cell
lysat
load
protein
level
determin
western
blot
c
total
intracellular
protein
reduc
treatment
particular
lm
h
volum
cell
lysat
load
gel
stain
coomassi
brilliant
blue
solut
distain
p
p
